COVID Conversations: Dexamethasone and the RECOVERY trials Recovery description:
In March 2020, the RECOVERY (Randomised Evaluation of COVid-19 thERapY) trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19, including low-dose dexamethasone (a steroid treatment), the first drug shown to improve survival. Hear from Professors Peter Horby, Professor of Emerging Infectious Diseases in the Nuffield Department of Medicine, and Martin Landray, Professor of Medicine and Epidemiology at the Nuffield Department of Population Health, about what we know so far, and their ongoing search for treatments that can aid our fight against the disease.
Please Support Now: Oxford has over 150 researchers working on the urgent response to the Coronavirus outbreak. Public donations of any size will be rapidly put to use in our frontline research. You can make a gift today at
To find more talks in our Covid Conversations series, go to
COVID Conversations: Dexamethasone and the RECOVERY trials Recovery Comments :